Preclinical Toxicology Studies of Recombinant Human Platelet-Derived Growth Factor-BB Either Alone or in Combination with Beta-Tricalcium Phosphate and Type I Collagen

Human platelet-derived growth factor-BB (hPDGF-BB) is a basic polypeptide growth factor released from platelets at the injury site. It is a multifunctional molecule that regulates DNA synthesis and cell division and induces biological effects that are implicated in tissue repair, atherosclerosis, inflammatory responses, and neoplastic diseases. This paper is an overview of the toxicology data generated from a broad testing platform to determine bone, soft tissue, and systemic responses following administration of rhPDGF-BB. Moreover, the systemic and local toxicity of recombinant human PDGF-BB (rhPDGF-BB) in combination with either beta-tricalcium phosphate (β-TCP) or collagen combined with β-TCP was studied to determine dermal sensitization, irritation, intramuscular tissue responses, pyrogenicity, genotoxicity, and hemolytic properties. All data strongly suggest that rhPDGF-BB either alone or in combination with β-TCP or collagen with β-TCP is biocompatible and has neither systemic nor local toxicity, supporting its safe use in enhancing wound healing in patients.

[1]  D. Matthews.  Synthetic Platelet-Derived Growth Factor (rhPDGF) May Improve Bone Fill Over β-Tricalcium Phosphate (β-TCP) Alone , 2007 .

[2]  K. Hirschi,et al.  Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact. , 1999, Circulation research.

[3]  M. Mohler,et al.  A review of nonclinical toxicology studies of becaplermin (rhPDGF-BB). , 1998, American journal of surgery.

[4]  K. Hirschi,et al.  PDGF, TGF-β, and Heterotypic Cell–Cell Interactions Mediate Endothelial Cell–induced Recruitment of 10T1/2 Cells and Their Differentiation to a Smooth Muscle Fate , 1998, The Journal of cell biology.

[5]  A. Caplan,et al.  Osteochondrogenic potential of marrow mesenchymal progenitor cells exposed to TGF‐β1 or PDGF‐BB as assayed in vivo and in vitro , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  E. Canalis,et al.  Effects of platelet‐derived growth factor on bone formation in vitro , 1989, Journal of cellular physiology.

[7]  R. Ross,et al.  The biology of platelet-derived growth factor , 1986, Cell.

[8]  A M Kligman,et al.  The identification of contact allergens by animal assay. The guinea pig maximization test. , 1970, The Journal of investigative dermatology.

[9]  D. Matthews.  Synthetic platelet-derived growth factor (rhPDGF) may improve bone fill over beta-tricalcium phosphate (beta-TCP) alone. , 2007, The journal of evidence-based dental practice.

[10]  S. Lynch.  Bone Regeneration Techniques in the Orofacial Region , 2005 .

[11]  E. Brogi,et al.  Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. , 1994, Circulation.

[12]  A. Boman,et al.  Guinea pig maximization test. , 1985, Current problems in dermatology.